As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Dicerna develops RNAi-based therapies to selectively silence genes that cause or contribute to disease
The Ahmedabad based hospital in association with Sankalp India Foundation had established the BMT unit in 2017
Vakrangee’s distribution network across rural India will help penetrate underserved markets
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
By combining Innovaccer's Data Activation Platform with HCL's robust healthcare data accelerator (hDATA) suite, organizations can enable patient-centricity, cost-optimization and compliance
Tecentriq is the first and only cancer immunotherapy approved for NSCLC in the adjuvant setting
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
Subscribe To Our Newsletter & Stay Updated
